Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Spatafora

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
European Urology Focus|October 14, 2019
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational TrialArcangelo Sebastianelli, Pietro Spatafora, Jacopo Frizzi, et al.
Medicina (Kaunas, Lithuania)|July 27, 2022
Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following ChemotherapyLucrezia Becattini, Calogero Saieva, Laura Doni, et al.
EMBO Reports|June 21, 2024
Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancerLuigi Ippolito, Assia Duatti, Marta Iozzo, et al.
Frontiers in Surgery|August 16, 2021
Prostate Cancer Characteristics in Renal Transplant Recipients: A 25-Year Experience From a Single CentrePietro Spatafora, Francesco Sessa, Simone Caroassai Grisanti, et al.
Journal of Clinical Medicine|August 1, 2019
Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational TrialArcangelo Sebastianelli, Pietro Spatafora, Jacopo Frizzi, et al.
Asian Journal of Urology|August 29, 2022
Contemporary techniques and outcomes of surgery for locally advanced renal cell carcinoma with focus on inferior vena cava thrombectomy: The value of a multidisciplinary teamRiccardo Campi, Paolo Barzaghi, Alessio Pecoraro, et al.
Cells|May 13, 2026
Senescent Stroma-Derived Glutamine: A Driver of Aggressiveness in Prostate and Ovarian Cancer CellsGiulia Lori, Caterina Mancini, Caterina Paffetti, et al.
Journal of Clinical Medicine|February 11, 2023
Transperineal Laser Ablation of the Prostate (TPLA) for Lower Urinary Tract Symptoms Due to Benign Prostatic ObstructionFrancesco Sessa, Paolo Polverino, Giampaolo Siena, et al.
Cells|December 23, 2022
Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian CancerElisa Pardella, Erica Pranzini, Ilaria Nesi, et al.
Molecular Oncology|June 26, 2025
Targeting carbonic anhydrase IX/XII prevents the anti-ferroptotic effect of stromal lactic acid in prostate carcinomaElisa Pardella, Giuseppina Comito, Luigi Ippolito, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
European Urology Focus|October 14, 2019
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational TrialArcangelo Sebastianelli, Pietro Spatafora, Jacopo Frizzi, et al.
Medicina (Kaunas, Lithuania)|July 27, 2022
Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following ChemotherapyLucrezia Becattini, Calogero Saieva, Laura Doni, et al.
EMBO Reports|June 21, 2024
Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancerLuigi Ippolito, Assia Duatti, Marta Iozzo, et al.
Frontiers in Surgery|August 16, 2021
Prostate Cancer Characteristics in Renal Transplant Recipients: A 25-Year Experience From a Single CentrePietro Spatafora, Francesco Sessa, Simone Caroassai Grisanti, et al.
Journal of Clinical Medicine|August 1, 2019
Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational TrialArcangelo Sebastianelli, Pietro Spatafora, Jacopo Frizzi, et al.
Asian Journal of Urology|August 29, 2022
Contemporary techniques and outcomes of surgery for locally advanced renal cell carcinoma with focus on inferior vena cava thrombectomy: The value of a multidisciplinary teamRiccardo Campi, Paolo Barzaghi, Alessio Pecoraro, et al.
Cells|May 13, 2026
Senescent Stroma-Derived Glutamine: A Driver of Aggressiveness in Prostate and Ovarian Cancer CellsGiulia Lori, Caterina Mancini, Caterina Paffetti, et al.
Journal of Clinical Medicine|February 11, 2023
Transperineal Laser Ablation of the Prostate (TPLA) for Lower Urinary Tract Symptoms Due to Benign Prostatic ObstructionFrancesco Sessa, Paolo Polverino, Giampaolo Siena, et al.
Cells|December 23, 2022
Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian CancerElisa Pardella, Erica Pranzini, Ilaria Nesi, et al.
Molecular Oncology|June 26, 2025
Targeting carbonic anhydrase IX/XII prevents the anti-ferroptotic effect of stromal lactic acid in prostate carcinomaElisa Pardella, Giuseppina Comito, Luigi Ippolito, et al.
Pageof 4